The field of obesity management is quickly evolving. New drug therapies and bariatric surgery are effective, but a larger understanding of social determinants, genetics, and the psychology behind obesity are proving to be essential pieces of the puzzle. Dismantling the myth that obesity is a lack of willpower or a “calories in, calories out” conundrum is necessary to shift the conversation away from placing blame and toward effective management.
Dr. Salvatore Carbone is professor in the Department of Kinesiology & Health Sciences, College of Humanities & Sciences at the Virginia Commonwealth University. Can you
Cardiometabolic health education leader CMHC announced that its digital education has been streamlined into 12 hubs organized by therapeutic or clinical topics for focused learning
In August 2023, Cardiometabolic Health Congress will host the annual Women’s Cardiometabolic Health and Wellness Masterclass at the Laguna Cliffs Marriott Resort & Spa Informed
Cardiometabolic Health Congress (CMHC) sat down with Dr. Keith C. Ferdinand, the Gerald S. Berenson Endowed Chair in preventive cardiology at Tulane School of Medicine
Experts in both obesity medicine and dermatology have a lot to say about Ozempic, the latest glucose-control drug being used for weight loss. According to
The roots of cardiometabolic disease begin in childhood, but many clinicians do not feel confident about screening, diagnosing, and treating these conditions early on. This
Obesity
Obesity
Cardiometabolic Disease
Cardiometabolic Disease
CMHC co-chair Christie Ballantyne, MD and Erin Michos, MD discuss the biology behind inflammation and obesity, obesity as an underappreciated but major CVD risk factor, and the ever-changing landscape of obesity treatment, with several approaches that have been recently approved or are in clinical development. They also share important practical pearls about the role of newer anti-obesity medications in conjunction with lifestyle for the long-term management of obesity. (Recorded at 2023 CMHC Spring, May 19, 2023.)
Watch Drs. Eckel and Harrison discuss some additional perspectives on the screening, diagnosis and emerging treatment options for NASH. Recorded Dec.1, 2022.
Watch CMHC faculty Dr. Barb discussing some practical pearls and the current treatment approaches for NASH. Recorded Dec.15, 2022.
CMHC Chair Robert Eckel and faculty Holly Wyatt, MD and Michelle Look, MD recap the obesity session topics discussed at the 16th Annual CMHC, including the importance of assessing and addressing pre-obesity, patient motivation advice, and considerations for long-term weight maintenance and obesity management.
CMHC Chair Robert Eckel, MD, recaps the session on rare obesity disorders discussed at the 16th Annual CMHC with session presenters Joan Han, MD, and Clair Francomano, MD. The session discussed monogenic disorders of obesity, including leptin pathway defects and Alström syndrome, as well as practical pearls for screening, diagnosis, and treatment.
NAFLD = non-alcoholic fatty liver disease; NASH = non-alcoholic steatohepatitis
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
Cardiometabolic Health Congress
1801 N Military Trail, Ste 110
Boca Raton, FL, 33431
Copyright © 2023, Cardiometabolic Health Congress. All Rights Reserved.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
